A new generation of weight-loss medicines is delivering results that exceed those of some of today's best-known treatments, according to a new study led by researchers at McGill University and the Lady Davis Institute for Medical Research.
Researchers reviewed 38 randomized clinical trials involving more than 25,000 adults with obesity or excess weight but not diabetes to evaluate the effectiveness and safety of GLP-1-based weight-loss drugs.
McGill University
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 16
- Comments 0